| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.24 | 6e-06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |